ArticleMolecular biotechnology2023

In Vitro and In Vivo Studies of a Heminecrolysin Toxin-VEGF Fusion Protein as a Novel Therapeutic for Solid Tumor Targeting.

Zahra Naderiyan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.